These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1166830)

  • 1. Iron metabolism in porphyria cutanea tarda.
    Reizenstein P; Höglund S; Landegren J; Carlmark B; Forsberg K
    Acta Med Scand; 1975; 198(1-2):95-9. PubMed ID: 1166830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron metabolism and its responses to allopurinol treatment in porphyria cutanea tarda.
    Burger T; Horváth T; Jávor T
    Acta Med Acad Sci Hung; 1978; 35(2):115-27. PubMed ID: 742338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda.
    Di Padova C; Marchesi L; Cainelli T; Gori G; Podenzani SA; Rovagnati P; Rizzardini M; Cantoni L
    Am J Med Sci; 1983; 285(1):2-12. PubMed ID: 6824014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of porphyria cutanea tarda with and without phlebotomy (author's transl)].
    Leonhardi G; Klähn KH; Gürenci J
    MMW Munch Med Wochenschr; 1977 Jan; 119(2):43-6. PubMed ID: 401939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phlebotomy and iron-overload in porphyria cutanea tarda.
    Kalivas JT; Pathak MA; Fitzpatrick TB
    Lancet; 1969 Jun; 1(7607):1184-7. PubMed ID: 4181840
    [No Abstract]   [Full Text] [Related]  

  • 9. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of iron in experimental porphyria and porphyria cutanea tarda.
    Siersema PD; van Helvoirt RP; Cleton-Soeteman MI; de Bruijn WC; Wilson JH; van Eijk HG
    Biol Trace Elem Res; 1992 Oct; 35(1):65-72. PubMed ID: 1384628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron and hepatic uroporphyrin synthesis. Relation in porphyria cutanea tarda.
    Felsher BF; Jones ML; Redeker AG
    JAMA; 1973 Nov; 226(6):663-5. PubMed ID: 4800611
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
    Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Borghi A; Ventura E
    J Lab Clin Med; 1986 Jan; 107(1):36-42. PubMed ID: 3941293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda.
    Lundvall O; Weinfeld A
    Acta Med Scand; 1968 Sep; 184(3):191-9. PubMed ID: 5703974
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of chloroquine in porphyria cutanea tarda].
    Herrero C; Muniesa A
    Med Cutan Ibero Lat Am; 1980; 8(4-6):139-45. PubMed ID: 7024672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda in association with hemosiderosis of the liver. Iron absorption studies and evaluation of therapy by phlebotomy.
    Strickland GT
    Am J Gastroenterol; 1968 Sep; 50(3):202-7. PubMed ID: 5677557
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of replenishment of iron stores after phlebotomy therapy in porphyria cutanea tarda.
    Lundvall O
    Acta Med Scand; 1971; 189(1-2):51-63. PubMed ID: 5166124
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intestinal absorption of iron observed in 2 cases of porphyria cutanea tarda].
    Cupella F; Pozzi U; Carena M; Schiavi A; Colombi R
    G Ital Med Lav; 1984; 6(5-6):259-60. PubMed ID: 6545217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Porphyrin metabolic disorders in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (8):67-71. PubMed ID: 2816038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.